Cargando…
Big dynorphin is a neuroprotector scaffold against amyloid β-peptide aggregation and cell toxicity
Amyloid β-peptide (Aβ) misfolding into β-sheet structures triggers neurotoxicity inducing Alzheimer’s disease (AD). Molecules able to reduce or to impair Aβ aggregation are highly relevant as possible AD treatments since they should protect against Aβ neurotoxicity. We have studied the effects of th...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582793/ https://www.ncbi.nlm.nih.gov/pubmed/36284704 http://dx.doi.org/10.1016/j.csbj.2022.10.014 |
_version_ | 1784812921942966272 |
---|---|
author | Gallego-Villarejo, Lucía Wallin, Cecilia Król, Sylwia Enrich-Bengoa, Jennifer Suades, Albert Aguilella-Arzo, Marcel Gomara, María José Haro, Isabel Wärmlander, Sebastian Muñoz, Francisco J. Gräslund, Astrid Perálvarez-Marín, Alex |
author_facet | Gallego-Villarejo, Lucía Wallin, Cecilia Król, Sylwia Enrich-Bengoa, Jennifer Suades, Albert Aguilella-Arzo, Marcel Gomara, María José Haro, Isabel Wärmlander, Sebastian Muñoz, Francisco J. Gräslund, Astrid Perálvarez-Marín, Alex |
author_sort | Gallego-Villarejo, Lucía |
collection | PubMed |
description | Amyloid β-peptide (Aβ) misfolding into β-sheet structures triggers neurotoxicity inducing Alzheimer’s disease (AD). Molecules able to reduce or to impair Aβ aggregation are highly relevant as possible AD treatments since they should protect against Aβ neurotoxicity. We have studied the effects of the interaction of dynorphins, a family of opioid neuropeptides, with Aβ(40) the most abundant species of Aβ. Biophysical measurements indicate that Aβ(40) interacts with Big Dynorphin (BigDyn), lowering the amount of hydrophobic aggregates, and slowing down the aggregation kinetics. As expected, we found that BigDyn protects against Aβ(40) aggregates when studied in human neuroblastoma cells by cell survival assays. The cross-interaction between BigDyn and Aβ(40) provides insight into the mechanism of amyloid pathophysiology and may open up new therapy possibilities. |
format | Online Article Text |
id | pubmed-9582793 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Research Network of Computational and Structural Biotechnology |
record_format | MEDLINE/PubMed |
spelling | pubmed-95827932022-10-24 Big dynorphin is a neuroprotector scaffold against amyloid β-peptide aggregation and cell toxicity Gallego-Villarejo, Lucía Wallin, Cecilia Król, Sylwia Enrich-Bengoa, Jennifer Suades, Albert Aguilella-Arzo, Marcel Gomara, María José Haro, Isabel Wärmlander, Sebastian Muñoz, Francisco J. Gräslund, Astrid Perálvarez-Marín, Alex Comput Struct Biotechnol J Special Issue articles from "Peptide structural conversions and cross-interactions in health and disease" edited by Alex Perálvarez-Marín Amyloid β-peptide (Aβ) misfolding into β-sheet structures triggers neurotoxicity inducing Alzheimer’s disease (AD). Molecules able to reduce or to impair Aβ aggregation are highly relevant as possible AD treatments since they should protect against Aβ neurotoxicity. We have studied the effects of the interaction of dynorphins, a family of opioid neuropeptides, with Aβ(40) the most abundant species of Aβ. Biophysical measurements indicate that Aβ(40) interacts with Big Dynorphin (BigDyn), lowering the amount of hydrophobic aggregates, and slowing down the aggregation kinetics. As expected, we found that BigDyn protects against Aβ(40) aggregates when studied in human neuroblastoma cells by cell survival assays. The cross-interaction between BigDyn and Aβ(40) provides insight into the mechanism of amyloid pathophysiology and may open up new therapy possibilities. Research Network of Computational and Structural Biotechnology 2022-10-14 /pmc/articles/PMC9582793/ /pubmed/36284704 http://dx.doi.org/10.1016/j.csbj.2022.10.014 Text en © 2022 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Special Issue articles from "Peptide structural conversions and cross-interactions in health and disease" edited by Alex Perálvarez-Marín Gallego-Villarejo, Lucía Wallin, Cecilia Król, Sylwia Enrich-Bengoa, Jennifer Suades, Albert Aguilella-Arzo, Marcel Gomara, María José Haro, Isabel Wärmlander, Sebastian Muñoz, Francisco J. Gräslund, Astrid Perálvarez-Marín, Alex Big dynorphin is a neuroprotector scaffold against amyloid β-peptide aggregation and cell toxicity |
title | Big dynorphin is a neuroprotector scaffold against amyloid β-peptide aggregation and cell toxicity |
title_full | Big dynorphin is a neuroprotector scaffold against amyloid β-peptide aggregation and cell toxicity |
title_fullStr | Big dynorphin is a neuroprotector scaffold against amyloid β-peptide aggregation and cell toxicity |
title_full_unstemmed | Big dynorphin is a neuroprotector scaffold against amyloid β-peptide aggregation and cell toxicity |
title_short | Big dynorphin is a neuroprotector scaffold against amyloid β-peptide aggregation and cell toxicity |
title_sort | big dynorphin is a neuroprotector scaffold against amyloid β-peptide aggregation and cell toxicity |
topic | Special Issue articles from "Peptide structural conversions and cross-interactions in health and disease" edited by Alex Perálvarez-Marín |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582793/ https://www.ncbi.nlm.nih.gov/pubmed/36284704 http://dx.doi.org/10.1016/j.csbj.2022.10.014 |
work_keys_str_mv | AT gallegovillarejolucia bigdynorphinisaneuroprotectorscaffoldagainstamyloidbpeptideaggregationandcelltoxicity AT wallincecilia bigdynorphinisaneuroprotectorscaffoldagainstamyloidbpeptideaggregationandcelltoxicity AT krolsylwia bigdynorphinisaneuroprotectorscaffoldagainstamyloidbpeptideaggregationandcelltoxicity AT enrichbengoajennifer bigdynorphinisaneuroprotectorscaffoldagainstamyloidbpeptideaggregationandcelltoxicity AT suadesalbert bigdynorphinisaneuroprotectorscaffoldagainstamyloidbpeptideaggregationandcelltoxicity AT aguilellaarzomarcel bigdynorphinisaneuroprotectorscaffoldagainstamyloidbpeptideaggregationandcelltoxicity AT gomaramariajose bigdynorphinisaneuroprotectorscaffoldagainstamyloidbpeptideaggregationandcelltoxicity AT haroisabel bigdynorphinisaneuroprotectorscaffoldagainstamyloidbpeptideaggregationandcelltoxicity AT warmlandersebastian bigdynorphinisaneuroprotectorscaffoldagainstamyloidbpeptideaggregationandcelltoxicity AT munozfranciscoj bigdynorphinisaneuroprotectorscaffoldagainstamyloidbpeptideaggregationandcelltoxicity AT graslundastrid bigdynorphinisaneuroprotectorscaffoldagainstamyloidbpeptideaggregationandcelltoxicity AT peralvarezmarinalex bigdynorphinisaneuroprotectorscaffoldagainstamyloidbpeptideaggregationandcelltoxicity |